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ABSTRACT
Objective: To determine the mortality rate following
total ankle replacement (TAR) and incidence of 90 day
pulmonary embolism (PE) along with the associated
risk factors.
Design: Data-linkage study of the UK National Joint
Registry (NJR) data and Hospital Episodes Statistics
(HES) database. Linkage was performed in a
deterministic fashion. HES episodes 90 days after the
index procedure were analysed for PE. Mortality data
were obtained pertaining to all the index procedures
from the NJR for analysis.
Participants: All primary and revision ankle
replacement patients captured on the NJR between
February 2008 and February 2013.
Results: The 90-day mortality following TAR was
0.13% (95% CI 0.03 to 0.52) and 1-year mortality was
0.72% (95% CI 0.40 to 1.30); no deaths were as a
result of PE. The incidence of PE within 90 days
following primary TAR was 0.51% (95% CI 0.23 to
1.13). There was only one PE following revision
surgery. Patients with an Royal College of Surgeons
Charlson score greater than zero were at 13 times
greater risk of PE (p=0.003).
Conclusions: There is low incidence of PE following
TAR, but multiple comorbidities are a leading risk
factor for its occurrence.
INTRODUCTION
Total ankle replacement (TAR) provides
patients with an improved functional outcome
that is maintained at 10 years with a cum-
ulative annual failure rate of 1.2%.1 The
National Institute for Healthcare and Clinical
Excellence (NICE) risk assessment tool cate-
gorises TAR as a high-risk procedure for pul-
monary embolism (PE),2 but the true
incidence of venous thromboembolism (VTE)
following TAR is largely unknown, with several
papers reporting a wide variation in incidence
ranging from 0% to 4.8% (table 1).3–14 These
studies demonstrate ambiguity of deﬁnition of
VTE; methodological ﬂaws; and small single
centre retrospective reviews.
An estimated 25 000 people die from hos-
pital acquired VTE in the UK every year.15
Indeed, mortality is a key quality of care indi-
cator outlined by the Keogh Report and its
reduction a vital ambition of the UK National
Health Service (NHS).16
VTE events are rare and difﬁcult to capture
in a single centre, but can be detected in sufﬁ-
cient numbers by large-scale national regis-
tries. It has been mandatory to input every
TAR into the NJR since 2010. A further advan-
tage to using registry data for analysis is the
diversity regarding the patient population,
surgeon and implant choice. It is therefore
representative of real-world practice.
In England, any patient admitted to an
NHS hospital is recorded on the Hospital
Episode Statistics (HES) database; currently,
more than 125 million records are captured
each year. Almost all suspected PEs are
admitted to hospital and should be recorded
on the HES database. Between April 2012
and April 2013, 23 257 patients were admit-
ted to NHS hospitals in England with PE.17
The aims of our study therefore were to
answer the following research questions
using linked NJR-HES data:
1. What is the rate of mortality following TAR?
2. What is the 90-day incidence of PE and
associated risk factors?
METHODS
Data linkage
Data from the NJR were linked to HES data
in a deterministic fashion. Deterministic
linkage requires an exact match of the ﬁelds
being linked from both data sets in order to
say that they are from the same patient. NJR
Strengths and limitations of this study
▪ The world’s largest cohort of ankle replacements.
▪ Data-linkage methodology reduces biases that
are present in single surgeon, single centre
reports of pulmonary embolism.
▪ Limited by a linkage rate of 73%.
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records for primary and revision procedures (From
February 2008 to February 2013) (1627 records) were
linked to 5 years of HES records (which equates to 90
million records) (ﬁgure 1). This is in contrast to prob-
abilistic linkage which estimates the likelihood that two
records are for the same individual, even if they disagree
on some ﬁelds.18 Linkage was conducted by the Health
& Social Care Information Centre. This was in line with
best linkage practice with application of the ‘separation
principle’ to allow the most ethical workﬂow.19 This prin-
ciple is used to protect patient data, with patient identi-
fying components and clinical components of a data set
kept separate. Identifying data are used by a group to
perform data linkage, while the research group uses
non-identifying data to perform the analysis.
A total of 1627 NJR records were linked to NJR data
that were captured on minimal data set forms completed
by the surgeon at the time of surgery and submitted by
the performing hospital. This is a mandated require-
ment in the UK NHS. For a primary ankle replacement,
the form is entitled an A1 form and for a revision ankle
replacement, an A2 form.20 21 The forms capture
patient demographics such as patient age, gender and
body mass index (BMI). The unit where the surgery is
performed is captured with the grade of surgeon per-
forming the surgery. The grade of surgeon is subdivided
into a consultant surgeon or trainee. Indication for
surgery, details of preoperative deformity and range of
motion are also collected. Further to this, the prosthesis
type, surgical approach, associated procedures, intrao-
perative complications and prophylaxis against venous
thromboembolic disease are recorded.20 21
Identification of PE
The ICD-10 (International Classiﬁcation of Disease V.10)
codes were used to search the linked data for episodes
of PE after the index procedure.22 Deep vein thrombosis
(DVT) was excluded from our analysis as these patients
are not admitted to hospital but instead are treated in
the community and hence are not recorded on the HES
database.6
Table 1 Studies reporting on thromboembolic events post-TAR
Study Source
Number
in study
Total VTE events
Number and
percentage
Deep vein
thrombosis
Number
and
percentage
Pulmonary
embolism
Number and
percentage
Barg, et al4a SC/MS 655 26 (3.97) 26 (3.97) NA
Haskell et al4b MC/MS 187 2 (1.07) NA NA
Hobson, et al5 SC/SS 123 0 (0) 0 (0) 0 (0)
Jameson, et al6 HES database 1633 1 (0.06) 0 (0) 1 (0.06)
Karantana, et al7 SC/SS 52 0 (0) 0 (0) 0 (0)
Knecht, et al8 SC/SS 67 1 (1.49) 0 (0) 1 (1.49)
Kumar, et al9 SC/SS 43 0 (0) 0 (0) 0 (0)
Lee, et al10 SC/SS 50 0 (0) 0 (0) 0 (0)
Rippstein, et al11 SC/MS 233 3 (1.29) 3 (1.29) 0 (0)
Rodrigues-Pinto12 MC/MS 119 0 (0) 0 (0) 0 (0)
Saltzman, et al13 SC/SS 42 2 (4.76) 2 (4.76) 0 (0)
Schweitzer, et al14 MC/MS 67 1 (1.49) 0 (0) 1 (1.49)
HES, Hospital Episode Statistics; MC, multicentre; MS, multiple surgeons; NA, not applicable; n, number; SC, single centre; SS, single
surgeon; VTE, venous thromboembolism; TAR, total knee replacement.
Figure 1 Flow chart showing the linkage of the NJR and
HES databases. Twenty-seven of the records remained
unlinked due to non-consent and the procedures being carried
out in non-NHS institutions where no HES record is created.
HES, Hospital Episode Statistics; NHS, National Health
Service; NJR, National Joint Registry.
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Identification of deaths following TAR
Mortality data were obtained separately from the NJR.
The NJR tracks mortality via its link with the Ofﬁce of
National Statistics and automatically ﬂags deaths at
90 days, 1 year, 2 years and 3 years.
Analytical approach
Factors related to increased risk of PE following primary
TAR were assessed. Several variables were investigated
including: age, sex, BMI, length of stay, indication for
surgery, implant type and ﬁxation, thromboprophylaxis,
preoperative range of motion and deformity, where the
implant was performed (NHS vs independent sector)
and comorbidities.
Comorbid conditions were deﬁned using the Royal
College of Surgeons Charlson score applied to HES
records in the 12 months preceding the index operation
for every patient. This is a validated tool that is a count
of chronic comorbid conditions that may affect the
outcome of surgery.23 We combined the comorbidity
count to form two groups for analysis; this was due to
the small numbers of PEs in each group.
An assessment of the similarities between the back-
ground characteristics and surgical factors of the PE and
no PE patient groups was conducted. The normality of
each continuous factor when broken down by the PE or
no PE patient groups was assessed using the Shapiro-Wilk
test. Student’s t-test were used to test whether there was a
difference in the means between the two groups when
normality was upheld. Mann-Whitney tests were used to
test whether the medians of the distributions were differ-
ent for skew distributions. The χ2 or Fisher’s exact tests
were used to test whether there was an association
between a categorical factor and patient group member-
ship. Since the number of PE outcome events was small,
the ratio of outcome events per factor was not sufﬁcient
to enable multivariable analysis of the effect of multiple
factors on PE.
For the purpose of analysis, age was divided into three
groups: <65, 65–75 and >75. BMI was divided into three
categories: a BMI of >18.5 is underweight; 18.5–25 was
classed as normal, and a BMI of >25 was classiﬁed as
overweight, with no further breakdown for obesity. PE
rate was also analysed in the context of unit volume. We
identiﬁed that those units performing more than 20 per
year (19 units) accounted for half of all ankle replace-
ments performed and those that did <20 per year
(163 units) accounted for the other half. We therefore
classed high volume units as those carrying out 20 ankle
replacements or more per year and low volume units as
those that performed <20 per year.
Owing to the low occurrence of PE, we combined
American Society of Anesthesiologists (ASA) grades to
form two groups. Analysis was conducted using R V.3.0.2
(R Foundation for Statistical Computing, Vienna,
Austria). Estimates of mortality rates were derived by the
Kaplan-Meier method using Stata/IC V.14.0 (StataCorp,
College Station, Texas, USA).
RESULTS
There were a total of 1627 NJR records comprising 1522
primary operations and 105 revisions. The overall match
rate with HES was 73% with 1110 matched primary pro-
cedures and 75 revisions.
The mean patient age of patients undergoing primary
TAR was 66.6 (SD 10.4). Forty-two per cent of these
patients were female. A total of 795 of the 1522 NJR
records gave details on patient BMI: the mean BMI was
29.1 (SD 5). Eighty-ﬁve of the primary procedures were
performed as a result of osteoarthritis with 10% having
rheumatoid arthritis as the indication; 98.5% were unce-
mented operations with 96% being performed via an
anterior approach.
The mean age of patients undergoing revision oper-
ation was 65 (SD 11.5). Forty per cent of these patients
were female. Fifty-two per cent of the 105 NJR records
gave details on patient BMI: the mean BMI was 27.7 (SD
9.8). The main indication for revision was infection
(26%) followed by persistent pain (17%) and aseptic
loosening of the tibia (15%). Fifty-four were uncemen-
ted revisions to another ankle replacement; whereas
11.5% involved fusion of the ankle joint from a TAR.
Mortality rate
Survival data were available for 1522 primary procedure
patients. The median follow-up time was 46 months
(range 2–88), during which 14 patients died. The 90-day
mortality following TAR was 0.13% (95% CI 0.03 to
0.52) and 1-year mortality was 0.72% (95% CI 0.40 to
1.30) (table 2). None of the deaths were as a result of
PE. When compared to the ONS age and sex standar-
dised death rates in the UK for 2013, the 90-day death
rate was 15 times lower and 1-year death rate was 2.8
times lower for patients who had a TAR. No deaths were
observed among the 105 revision patients who had a
median follow-up time of 44 months (range 30–65).
PE rate
Of the 1110 linked primary procedures, 5 had a PE
within 90 days of surgery, giving an incidence rate of
Table 2 Kaplan-Meier estimates of the cumulative
percentage probability of mortality at 90 days, 1, 2 and
3 years postoperation (95% CI)
Number of
deaths Rate (95% CI) SMR
90 days 2 0.13 (0.03 to 0.52) 0.07
1 year 11 0.72 (0.40 to 1.30) 0.36
2 years 13 0.85 (0.50 to 1.47) 0.42
3 years 14 0.92 (0.55 to 1.55) 0.46
Standardised Mortality Ratio was calculated using the age and
sex adjusted mortality data from the ONS.31
SMR, Mortality rate in TAR/age+sex adjusted mortality rate in the
general population in 2013.
ONS, Office for National Statistics; SMR, Standardised Mortality
Ratio; TAR, total knee replacement.
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0.51% (95% CI 0.23 to 1.13) at a mean of 56 days. All
patients with a PE had an uncemented prosthesis via an
anterior approach and received both mechanical and
chemical thromboprophylaxis. Only 1 of the 75 revision
procedures was recorded as having a PE.
There were no fatal PEs. Although no statistical sig-
niﬁcance was noted (p=0.09) the 90-day rate of PE was
greater among the 65–74 years age group (0.80%), and
over 75s (0.74%) in comparison to the under 65 years
age group where no PEs occurred (table 3). All the
patients who had a PE were overweight. No
occurrences of PE were found in patients with a BMI of
<25 (p=0.9).
Seventy-three per cent of the patients who did not
suffer a PE (no PE Group) had received both mechani-
cal and chemical prophylaxis. Three per cent of patients
received no thromboprophylaxis and yet none of them
suffered a PE (table 3). Distribution of ASA Grade was
similar in patients who suffered and did not suffer a PE
(table 3).
Patients with an Royal College of Surgeons (RCS)
Charlson score greater than zero were at 13 times
Table 3 Analysis of patients that had PE versus no-PE 90 days post-primary TAR
PE No PE PE rate (%)
Significance test,
p value
Age n (proportion) n (proportion)
<65 0 (0) 463 (0.42) 0.00 0.09
65–74 3 (0.6) 373 (0.34) 0.80
>75 2 (0.4) 269 (0.24) 0.74
Length of stay mean (range) mean (range)
3.2 (1–9) 3.8 (0–46) 0.26
BMI n (proportion) n (proportion)
Underweight 0 (0) 4 (0.01) 0.00 0.9
Normal 0 (0) 122 (0.2) 0.00
Overweight 3 (1) 487 (0.79) 0.61
Missing data 2 492
Gender percentage percentage
Female 20 43 0.3
Indications n (proportion) n (proportion)
Osteoarthritis 5 (1.0) 938 (0.849) 0.50 0.9
Rheumatoid arthritis 0 (0) 108 (0.098) 0.00
Inflammatory 0 (0) 23 (0.028) 0.00
Other 0 (0) 36 (0.033) 0.00
Operation n (proportion) n (proportion)
Uncemented 5 (1.0) 1087 (0.98) 0.46 0.9
Cement 0 (0) 15 (0.014) 0.00
Hybrid 0 (0) 3 (0.003) 0.00
ASA n (proportion) n (proportion)
1–2 4 (0.8) 931 (0.84) 0.43 0.58
3–4 1 (0.2) 174 (0.16) 0.60
Charlson n (proportion) n (proportion)
0 4 1085 0.4 0.003
>0 1 20 5.0
Prophylaxis n (proportion) n (proportion)
Both 5 (1) 809 (0.73) 1.0 0.73
Chemical only 0 (0) 209 (0.18) 0.0
Mechanical only 0 (0) 54 (0.05) 0.0
None 0 (0) 33 (0.03) 0.0
Deformity n (proportion) n (proportion)
Neutral 2 (0.5) 451 (0.73) 0.44 0.3
Valgus 1 (0.25) 75 (0.12) 1.30
Varus 1 (0.25) 92 (0.15) 1.10
Missing data 1 487
Dorsiflexion n (proportion) n (proportion)
5–20 2 (0.4) 582 (0.53) 0.34 0.5
Neutral 2 (0.4) 421 (0.38) 0.47
Fix equinus 1 (0.2) 102 (0.1) 0.97
Continued
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greater risk of PE (p=0.003). When looking at ankle
deformity and range of motion, we found a higher rate
of PE with varus deformity and ﬁxed equinus, but the
differences were not statistically signiﬁcant (table 3).
DISCUSSION
The 90-day mortality rate following TAR is 0.13%. This is
lower than that reported for hip replacement (0.5%)
and knee replacement (0.34%).24
The incidence of PE within 90 days of ankle replace-
ment surgery is 0.51% (95% CI 0.23 to 1.13), with a
mean event time of 56 days after surgery. A review of the
literature suggests the published rate of PE to be 0.17%
(table 1), which is signiﬁcantly lower than the incidence
revealed by this study. This may represent reporting bias
in that, in other reported series, patients were admitted
under medical teams and not picked up by the surgical
team. The strength in our methodology is that it has the
ability to capture readmissions anywhere in the UK
under any clinician, regardless of where the TAR was
performed, and hence meets one of our key aims to use
registry data to determine a true incidence of PE follow-
ing ankle replacement.
A previous study used HES data only to determine PE
rates following TAR determined by a search of a series
of relevant treatment codes (ICD) and reported a PE
rate of 0.06% post-TAR.6 The current study used a more
robust data linkage methodology to identify several
more PEs. This highlights the advantage of using one
data set to validate another to ensure that data are not
lost.
A national audit of a large UK trust into clinical coding
revealed that in orthopaedics 20% of diagnosis and 19%
of procedures are coded inaccurately.25 Therefore,
although we employed a robust method to identify ankle
replacement more accurately, the actual identiﬁcation of
PE was still limited by accuracy of clinical coding.
All patients who suffered PE had both mechanical and
chemical prophylaxis. Other studies have shown similar
rates of PE in foot and ankle surgery and argued that
evidence for routine thromboprophylaxis use is
weak.26 27 It is difﬁcult to argue that thromboprophylaxis
is not warranted, based on negative ﬁndings in a treated
group; however, this study showed that in the 3% of
patients who received no routine thromboprophylaxis,
none of them suffered a PE (table 3).
Comorbidity surfaced as the leading predictor of PE
in patients undergoing TAR with a comorbidity count
>0, leading to increased risk of PE by a multiple of 13.
The RCS Charlson score looks at 14 disease categories
developed by a consensus group.23 Until now, the exist-
ing literature has focused on the PE rates in foot and
ankle surgery as a whole, mostly including trauma cases
due to the higher volumes compared to elective
surgery. Some have shown that the presence of any
comorbid conditions doubles the rate of PE,28 and
Jameson et al found that a Charlson score of 2 or more
signiﬁcantly increased the risk of PE in ankle fractures
treated operatively. Other groups have shown speciﬁc
comorbidity, such as diabetes double the risk of PE.29
The existing body of work is supported by this study in
that it emphasises the importance of comorbidity and
PE risk.
Table 3 Continued
PE No PE PE rate (%)
Significance test,
p value
Plantarflexion n (proportion) n (proportion)
16–45 1 (0.25) 376 (0.4) 0.30 0.9
5–15 3 (0.75) 574 (0.6) 0.50
Missing data 1 155
Unit volume per year n (proportion) n (proportion)
>20 3 (0.6) 643 (0.58) 0.46 0.9
<20 2 (0.4) 462 (0.42) 0.43
Organisation type n (proportion) n (proportion)
NHS Hospital 3 (0.6) 979 (0.89) 0.3 0.1
Independent hospital 1 (0.2) 74 (0.07) 1.3
Independent treatment centre 1 (0.2) 52 (0.05) 1.9
Previous operation n (proportion) n (proportion)
None 3 (0.75) 397 (0.54) 0.75 0.9
Fusion 0 (0) 7 (0.01) 0.0
Ankle ORIF 0 (0) 59 (0.08) 0.0
Tibial osteotomy 0 (0) 4 (0.005) 0.0
Other 0 (0) 69 (0.09) 0.0
Previous fracture 1 (0.25) 204 (0.28) 0.5
Missing data 1 365
ASA, American Society of Anesthesiologists; BMI, body mass index; n, number of patients; NHS, National Health Service; ORIF, open
reduction and internal fixation; PE, pulmonary embolism; TAR, total knee replacement.
Zaidi R, et al. BMJ Open 2016;6:e011947. doi:10.1136/bmjopen-2016-011947 5
Open Access
group.bmj.com on June 23, 2016 - Published by http://bmjopen.bmj.com/Downloaded from 
We showed a trend towards increased risk of PE with
age over 65 years and by being overweight. This is
similar to the ﬁnding of Shibuya et al28 who found a sig-
niﬁcant increase in PE risk with increasing age and BMI
when looking at lower limb trauma. Our ﬁndings,
however, did not reach statistical signiﬁcance.
A limitation of this study is that we were unable to
record DVT as well as PE to give an overall VTE rate.
This is largely because the HES database only records
admissions to hospital, whereas DVTs are invariably
treated in the outpatient setting and hence not admit-
ted.6 As a result, the national rate of VTE associated
with TAR is unknown. Nonetheless, the PE rate is more
accurate as PEs and expected PEs are invariably admit-
ted to hospital. Another limitation was that only 73%
of the NJR records were linked to the HES database.
This 27% of non-linked records includes both patients
who did not sign their consent to enable data linkage,
and also patients where the surgery was carried out in
the independent sector where no HES record is
kept.30 Despite these limitations, this still represents
data from the largest cohort of ankle replacements
until now.
A further limitation is not having available data on the
duration of surgery and tourniquet use, which are pos-
sible factors that might inﬂuence VTE. None of this data
is captured on the NJR nor the HES database.
Owing to the small number of PE events, it is possible
that a type II error occurred and that risk factors existed
but did not reach statistical signiﬁcance with the cohort
size in this study. These risk factors will become clear as
the number of NJR records increase over time.
Increasing patient consent and ability to link records
from the independent sector will also increase the power
of any future analysis.
CONCLUSION
This study demonstrates that the rate of PE following
TAR is low (0.51%) and that within the initial 3-year
period of the UK National Joint Registry, no fatal PEs
occurred. The 90-day mortality rate following TAR is
0.13%, which is lower than that reported for hip replace-
ment and knee replacement.
Multiple comorbidity is the leading risk factor for PE
and must be taken into account in the treatment and
informed consenting process for patients undergoing TAR.
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